Replies to post #231332 on Avid Bioservices Inc (CDMO)

[md1225]

Late Breaking? 12 noon 8/26 not announced yet? Dr. Hutchins chairman? Maybe just maybe....

[biopharm]

Jerry McMahon, Ph.D., President & CEO, Kolltan Pharmaceuticals

TAM receptor tyrosine kinases and their cognate ligands play a key role in immune homeostasis through signaling in macrophage and dendritic cells and regulating the adaptive immune response. Modulation of the activation of these receptors may up- or down-regulate immune homeostasis for the treatment of cancer and other diseases. Inhibition of Axl and MerTK are under investigation to potentiate the effectiveness of biologic agents that interfere with T cell checkpoints in tumor immunology.

Kolltan collaborating with Peregrine Pharmaceuticals by connecting these dots...

The TAM family: phosphatidylserine-sensing receptor tyrosine kinases gone awry in cancer
http://www.nature.com/nrc/journal/v14/n12/full/nrc3847.html